A Case of Corticobasal Syndrome and Posterior Cortical Atrophy With Biomarkers of Alzheimer Disease

被引:1
作者
Sugimura, Yoko [1 ,2 ]
Baba, Toru [1 ]
Ezura, Michinori [3 ]
Kikuchi, Akio [3 ,4 ]
Hasegawa, Takafumi [3 ]
Nagano, Isao [5 ]
Suzuki, Kyoko [6 ]
Takeda, Atsushi [1 ,2 ,7 ]
机构
[1] Tohoku Univ, Natl Hosp Org Sendai Nishitaga Hosp, Grad Sch Med, Dept Neurol, Sendai, Japan
[2] Tohoku Univ, Grad Sch Med, Dept Cognit & Motor Aging, Sendai, Japan
[3] Tohoku Univ, Grad Sch Med, Dept Neurol, Sendai, Japan
[4] Yamagata Prefectural Univ Hlth Sci, Dept Occupat Therapy, Yamagata, Japan
[5] Natl Hosp Org, Miyagi Hosp, Dept Neurol, Watarai, Miyagi, Japan
[6] Tohoku Univ, Grad Sch Med, Dept Behav Neurol & Cognit Neurosci, Sendai, Japan
[7] Natl Hosp Org, Sendai Nishitaga Hosp, Dept Neurol, 2-11-11,Kagitorihoncho,Taihaku Ku, Sendai, Miyagi, Japan
关键词
CBS; AD; PCA; biomarker; DIAGNOSIS;
D O I
10.1097/WAD.0000000000000560
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Corticobasal syndrome is a clinical entity characterized by asymmetric akinetic rigidity and a variety of higher cortical dysfunction. Predicting background pathology of corticobasal syndrome is rather challenging; however, clinical and neuroimaging findings may provide a clue to its etiopathological origin. Visuospatial dysfunction of posterior cortical atrophy and logopenic-type language impairment indicate the presence of Alzheimer's disease-related pathology, and they provide useful information in distinguishing Alzheimer's disease from other types of corticobasal syndrome. Here we describe a case of corticobasal syndrome who showed characteristic visuospatial symptoms with imaging evidence of Alzheimer's disease supported by amyloid-PET and tau/astrogliosis-PET. Early, accurate diagnosis based on clinical features and predictable biomarkers is mandatory to the success of early intervention in corticobasal syndrome associated with Alzheimer's disease.
引用
收藏
页码:243 / 245
页数:3
相关论文
共 50 条
  • [31] Plasma pTau181 predicts cortical brain atrophy in aging and Alzheimer's disease
    Tissot, Cecile
    Benedet, Andrea L.
    Therriault, Joseph
    Pascoal, Tharick A.
    Lussier, Firoza Z.
    Saha-Chaudhuri, Paramita
    Chamoun, Mira
    Savard, Melissa
    Mathotaarachchi, Sulantha S.
    Bezgin, Gleb
    Wang, Yi-Ting
    Fernandez Arias, Jaime
    Rodriguez, Juan Lantero
    Snellman, Anniina
    Ashton, Nicholas J.
    Karikari, Thomas K.
    Blennow, Kaj
    Zetterberg, Henrik
    De Villers-Sidani, Etienne
    Huot, Philippe
    Gauthier, Serge
    Rosa-Neto, Pedro
    ALZHEIMERS RESEARCH & THERAPY, 2021, 13 (01)
  • [32] A Review of Biomarkers for Alzheimer’s Disease in Down Syndrome
    Lee N.-C.
    Chien Y.-H.
    Hwu W.-L.
    Neurology and Therapy, 2017, 6 (Suppl 1) : 69 - 81
  • [33] Is the pathology of posterior cortical atrophy clinically predictable?
    Cipriano, Lorenzo
    Oliva, Mariano
    Puoti, Gianfranco
    Signoriello, Elisabetta
    Bonavita, Simona
    Coppola, Cinzia
    REVIEWS IN THE NEUROSCIENCES, 2022, 33 (08) : 849 - 858
  • [34] Picture Agnosia as a Characteristic of Posterior Cortical Atrophy
    Sugimoto, Azusa
    Midorikawa, Akira
    Koyama, Shinichi
    Futamura, Akinori
    Hieda, Sotaro
    Kawamura, Mitsuru
    EUROPEAN NEUROLOGY, 2012, 68 (01) : 34 - 41
  • [35] Organic Anxiety Disorder in Posterior Cortical Atrophy
    Linsmayer, Denise
    Kindler, Christoph
    Anheier, Wiebke
    Reiff, Julia
    Suppa, Per
    Braus, Dieter F.
    PSYCHIATRISCHE PRAXIS, 2018, 45 (05) : 269 - 272
  • [36] Tau-PET Binding Distinguishes Patients With Early-stage Posterior Cortical Atrophy From Amnestic Alzheimer Disease Dementia
    Day, Gregory S.
    Gordon, Brian A.
    Jackson, Kelley
    Christensen, Jon J.
    Ponisio, Maria Rosana
    Su, Yi
    Ances, Beau M.
    Benzinger, Tammie L. S.
    Morris, John C.
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2017, 31 (02) : 87 - 93
  • [37] Biomarkers in Alzheimer's disease
    Rajendran, Kayalvizhi
    Krishnan, Uma Maheswari
    CLINICA CHIMICA ACTA, 2024, 562
  • [38] Clinical Phenotypes in Corticobasal Syndrome with or without Amyloidosis Biomarkers
    Benvenutto, Agnes
    Guedj, Eric
    Felician, Olivier
    Eusebio, Alexandre
    Azulay, Jean-Philippe
    Ceccaldi, Mathieu
    Koric, Lejla
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 74 (01) : 331 - 343
  • [39] Corticobasal syndrome due to sporadic Creutzfeldt-Jakob disease: a review and neuropsychological case report
    Gonzalez, David Andres
    Soble, Jason R.
    CLINICAL NEUROPSYCHOLOGIST, 2017, 31 (03) : 676 - 689
  • [40] Plasma biomarkers are associated with agitation and regional brain atrophy in Alzheimer's disease
    Hsu, Jung-Lung
    Lee, Wei-Ju
    Liao, Yi-Chu
    Lirng, Jiing-Feng
    Wang, Shuu-Jiun
    Fuh, Jong-Ling
    SCIENTIFIC REPORTS, 2017, 7